Skip to main content
Download PDF

Correction to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts

Respiratory Research volume 22, Article number: 223 (2021) Cite this article

The Original Article was published on 28 June 2021

Correction to: Respir Res (2021) 22:187 https://doi.org/10.1186/s12931-021-01773-1

The original version of this article unfortunately contained a mistake [1]. The minor correction of Table 1 was missing. That is, the text ‘FF’ should be ‘GFF’.

The correct Table 1 is given in this erratum.

Table 1 Demographic and baseline disease characteristics (mITT population)
Full size table

The original article has been corrected.

Reference

  1. Muro S, Sugiura H, Darken P, Dorinsky P. Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts. Respir Res. 2021;22:187. https://doi.org/10.1186/s12931-021-01773-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, Nara Medical University Graduate School of Medicine, 840 Shijo-cho, Kashihara-shi, 634-8521, Nara, Japan

    Shigeo Muro

  2. Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan

    Hisatoshi Sugiura

  3. AstraZeneca, Wilmington, DE, USA

    Patrick Darken

  4. AstraZeneca, Durham, NC, USA

    Paul Dorinsky

Authors
  1. Shigeo Muro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisatoshi Sugiura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick Darken
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul Dorinsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shigeo Muro.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Muro, S., Sugiura, H., Darken, P. et al. Correction to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts. Respir Res 22, 223 (2021). https://doi.org/10.1186/s12931-021-01803-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12931-021-01803-y

Respiratory Research

ISSN: 1465-993X

Contact us